menu
    • menu

    Company profile for Egetis Therapeutics

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Egetis Therapeutics is an integrated pharmaceutical company specializing in late-stage development and commercialization of treatments for serious diseases with high unmet needs, particularly in the orphan drug sector.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Egetis TherapeuticsSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Klara Norra Kyrkogata 26 SE 111 22 Stockholm
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Egetis Appoints Tiago Nunes As Chief Medical Officer
    Egetis Appoints Tiago Nunes As Chief Medical Officer

    09 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-09/egetis-appoints-tiago-nunes-as-chief-medical-officer

    PHARMIWEB
    09 Apr 2026
    Share Share
    FDA Priority Review to Egetis' Emcitate NDA for MCT8 Deficiency
    FDA Priority Review to Egetis' Emcitate NDA for MCT8 Deficiency

    27 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-27/egetis-announces-fda-acceptance-and-priority-review-of-nda-for-emcitate-r-tiratricol-for-mct8-def

    PHARMIWEB
    27 Mar 2026
    Share Share
    Egetis Therapeutics Launches MCT8 Deficiency Educational Websites
    Egetis Therapeutics Launches MCT8 Deficiency Educational Websites

    02 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-02/egetis-therapeutics-launches-educational-websites-on-mct8-deficiency-for-physicians-and-caregivers

    PHARMIWEB
    02 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search